Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia

  • Authors:
    • Hong Wang
    • Guimei Shen
    • Mengsi Liu
    • Linjuan Mao
    • Hui Mao
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Reproductive Center, The Affiliated Hospital of Yunnan University, Kunming, Yunnan 650000, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 41
    |
    Published online on: November 12, 2021
       https://doi.org/10.3892/etm.2021.10963
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Preeclampsia is a common syndrome in pregnancy and a leading cause of mortality of pregnant females and their infants. To investigate the diagnostic and prognostic utility of lncRNA T‑cell leukemia/lymphoma 6 (TCL6) in patients with preeclampsia, 120 singleton pregnant females with preeclampsia and another 100 healthy pregnant control subjects were analyzed in the present study. The expression of lncRNA TCL6 in the serum of the included patients was detected. Receiver operating characteristic curve analysis was applied to evaluate the efficiency of lncRNA TCL6 in terms of preeclampsia diagnosis and grading. Kaplan‑Meier analysis was adopted to assess the effect of lncRNA TCL6 expression on the rate of adverse pregnancy. Multivariate logistic regression was used to determine high‑risk factors of adverse pregnancy. The results indicated that lncRNA TCL6 was significantly increased in the serum of patients with preeclampsia. Furthermore, TCL6 was elevated in subgroups of patients with early‑onset or severe preeclampsia and with Haemolysis, Elevated Liver enzymes and Low Platelet count syndrome in comparison with other patients with preeclampsia. High expression of TCL6 in pregnant females corresponded to a higher rate of adverse pregnancy outcomes. Severe preeclampsia, early‑onset preeclampsia and high TCL6 expression were identified as independent risk factors for adverse pregnancy outcomes. For each unit increase in TCL6 expression, a 9.5‑fold increase of the risk of adverse maternal and fetal outcomes was determined. Collectively, high expression of lncRNA TCL6 may assist the diagnosis and grading of preeclampsia and may be adopted as an independent risk factor for adverse pregnancy outcomes.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Bokslag A, van Weissenbruch M, Mol BW and de Groot CJ: Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 102:47–50. 2016.PubMed/NCBI View Article : Google Scholar

2 

Pauli JM and Repke JT: Preeclampsia: Short-term and Long-term Implications. Obstet Gynecol Clin North Am. 42:299–313. 2015.PubMed/NCBI View Article : Google Scholar

3 

Ahmed A, Rezai H and Broadway-Stringer S: Evidence-Based Revised View of the Pathophysiology of Preeclampsia. Adv Exp Med Biol. 956:355–374. 2017.PubMed/NCBI View Article : Google Scholar

4 

Balogun OA and Sibai BM: Counseling, Management, and Outcome in Women With Severe Preeclampsia at 23 to 28 Weeks' Gestation. Clin Obstet Gynecol. 60:183–189. 2017.PubMed/NCBI View Article : Google Scholar

5 

Aloizos S, Seretis C, Liakos N, Aravosita P, Mystakelli C, Kanna E and Gourgiotis S: HELLP syndrome: Understanding and management of a pregnancy-specific disease. J Obstet Gynaecol. 33:331–337. 2013.PubMed/NCBI View Article : Google Scholar

6 

Sones JL and Davisson RL: Preeclampsia, of mice and women. Physiol Genomics. 48:565–572. 2016.PubMed/NCBI View Article : Google Scholar

7 

Nagy B: Cell-free nucleic acids in prenatal diagnosis and pregnancy-associated diseases. EJIFCC. 30:215–223. 2019.PubMed/NCBI

8 

McAninch D, Roberts CT and Bianco-Miotto T: Mechanistic Insight into Long Noncoding RNAs and the Placenta. Int J Mol Sci. 18(18)2017.PubMed/NCBI View Article : Google Scholar

9 

Saitou M, Sugimoto J, Hatakeyama T, Russo G and Isobe M: Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene. 19:2796–2802. 2000.PubMed/NCBI View Article : Google Scholar

10 

Chen Z, Zhuang Q, Cheng K, Ming Y, Zhao Y, Ye Q and Zhang S: Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells. J Cancer. 11:1383–1392. 2020.PubMed/NCBI View Article : Google Scholar

11 

Cuadros M, Andrades Á, Coira IF, Baliñas C, Rodríguez MI, Álvarez-Pérez JC, Peinado P, Arenas AM, García DJ, Jiménez P, et al: Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia. Blood Cancer J. 9(93)2019.PubMed/NCBI View Article : Google Scholar

12 

Luo LH, Jin M, Wang LQ, Xu GJ, Lin ZY, Yu DD, Yang SL, Ran RZ, Wu G and Zhang T: Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. J Cell Physiol. 235:6154–6166. 2020.PubMed/NCBI View Article : Google Scholar

13 

Zhang Y, Li Z, Chen M, Chen H, Zhong Q, Liang L and Li B: lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer. Breast Cancer. 27:573–585. 2020.PubMed/NCBI View Article : Google Scholar

14 

Liu LP and Gong YB: LncRNA-TCL6 promotes early abortion and inhibits placenta implantation via the EGFR pathway. Eur Rev Med Pharmacol Sci. 22:7105–7112. 2018.PubMed/NCBI View Article : Google Scholar

15 

Wu JL, Wang YG, Gao GM, Feng L, Guo N and Zhang CX: Overexpression of lncRNA TCL6 promotes preeclampsia progression by regulating PTEN. Eur Rev Med Pharmacol Sci. 23:4066–4072. 2019.PubMed/NCBI View Article : Google Scholar

16 

No authors listed. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 122:1122–1131. 2013.PubMed/NCBI View Article : Google Scholar

17 

Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association and Hypertensive Disorders in Pregnancy Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association. Diagnosis and treatment guideline of hypertensive disorders in pregnancy. Zhonghua Fu Chan Ke Za Zhi. 50:721–728. 2015.PubMed/NCBI(In Chinese).

18 

Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar

19 

Hui D and Hladunewich MA: Chronic Kidney Disease and Pregnancy. Obstet Gynecol. 133:1182–1194. 2019.PubMed/NCBI View Article : Google Scholar

20 

Marsh CA and Hecker E: Maternal obesity and adverse reproductive outcomes: Reducing the risk. Obstet Gynecol Surv. 69:622–628. 2014.PubMed/NCBI View Article : Google Scholar

21 

Reddy UM, Wapner RJ, Rebar RW and Tasca RJ: Infertility, assisted reproductive technology, and adverse pregnancy outcomes: Executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol. 109:967–977. 2007.PubMed/NCBI View Article : Google Scholar

22 

Ashworth DC, Maule SP, Stewart F, Nathan HL, Shennan AH and Chappell LC: Setting and techniques for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev. 8(CD012739)2020.PubMed/NCBI View Article : Google Scholar

23 

Han Q, Zheng W, Guo XD, Zhang D, Liu HF, Yu L and Yan JY: A new predicting model of preeclampsia based on peripheral blood test value. Eur Rev Med Pharmacol Sci. 24:7222–7229. 2020.PubMed/NCBI View Article : Google Scholar

24 

Morris RK, Riley RD, Doug M, Deeks JJ and Kilby MD: Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: Systematic review and meta-analysis. BMJ. 345 (jul09 1)(e4342)2012.PubMed/NCBI View Article : Google Scholar

25 

Song X, Luo X, Gao Q, Wang Y, Gao Q and Long W: Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia. Curr Drug Targets. 18:1165–1170. 2017.PubMed/NCBI View Article : Google Scholar

26 

Cornette J, Herzog E, Buijs EA, Duvekot JJ, Rizopoulos D, Hop WC, Tibboel D and Steegers EA: Microcirculation in women with severe pre-eclampsia and HELLP syndrome: A case-control study. BJOG. 121:363–370. 2014.PubMed/NCBI View Article : Google Scholar

27 

Guida JPS, Surita FG, Parpinelli MA and Costa ML: Preterm Preeclampsia and Timing of Delivery: A Systematic Literature Review. Rev Bras Ginecol Obstet. 39:622–631. 2017.PubMed/NCBI View Article : Google Scholar

28 

Lisonkova S and Joseph KS: Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 209:544.e1–544.e12. 2013.PubMed/NCBI View Article : Google Scholar

29 

Li LJ, Wu XY, Tan SW, Xie ZJ, Pan XM, Pan SW, Bai WR, Li HJ, Liu HL, Jiang J, et al: Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients. Gastroenterol Rep (Oxf). 7:434–443. 2019.PubMed/NCBI View Article : Google Scholar

30 

Tao S, Wang W, Liu P, Wang H and Chen W: Long non-coding RNA T-cell leukemia/lymphoma 6 serves as a sponge for miR-21 modulating the cell proliferation of retinoblastoma through PTEN. Korean J Physiol Pharmacol. 23:449–458. 2019.PubMed/NCBI View Article : Google Scholar

31 

Redman C: The six stages of pre-eclampsia. Pregnancy Hypertens. 4(246)2014.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang H, Shen G, Liu M, Mao L and Mao H: Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia. Exp Ther Med 23: 41, 2022.
APA
Wang, H., Shen, G., Liu, M., Mao, L., & Mao, H. (2022). Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia. Experimental and Therapeutic Medicine, 23, 41. https://doi.org/10.3892/etm.2021.10963
MLA
Wang, H., Shen, G., Liu, M., Mao, L., Mao, H."Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia". Experimental and Therapeutic Medicine 23.1 (2022): 41.
Chicago
Wang, H., Shen, G., Liu, M., Mao, L., Mao, H."Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia". Experimental and Therapeutic Medicine 23, no. 1 (2022): 41. https://doi.org/10.3892/etm.2021.10963
Copy and paste a formatted citation
x
Spandidos Publications style
Wang H, Shen G, Liu M, Mao L and Mao H: Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia. Exp Ther Med 23: 41, 2022.
APA
Wang, H., Shen, G., Liu, M., Mao, L., & Mao, H. (2022). Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia. Experimental and Therapeutic Medicine, 23, 41. https://doi.org/10.3892/etm.2021.10963
MLA
Wang, H., Shen, G., Liu, M., Mao, L., Mao, H."Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia". Experimental and Therapeutic Medicine 23.1 (2022): 41.
Chicago
Wang, H., Shen, G., Liu, M., Mao, L., Mao, H."Expression and clinical significance of lncRNA TCL6 in serum of patients with preeclampsia". Experimental and Therapeutic Medicine 23, no. 1 (2022): 41. https://doi.org/10.3892/etm.2021.10963
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team